🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST

Lycia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
60.9419.2730.59
Short-Term Investments
63.3859.85107.43
Cash & Short-Term Investments
124.3279.12138.02
Cash Growth
--42.67%-
Prepaid Expenses
3.41.511.81
Total Current Assets
127.7280.63139.83
Property, Plant & Equipment
4.354.357.89
Long-Term Investments
23.7712.073.01
Other Long-Term Assets
0.920.160.18
Total Assets
156.7697.22150.91

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
1.4112.27
Accrued Expenses
5.944.4114.39
Current Portion of Leases
1.461.021.85
Current Unearned Revenue
--4.74
Other Current Liabilities
1.330.060.08
Total Current Liabilities
10.146.4923.33
Long-Term Leases
1.711.732.92
Other Long-Term Liabilities
--0.25
Total Liabilities
11.858.2126.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
4.714.122.92
Retained Earnings
-136.76-117.56-81.1
Comprehensive Income & Other
-0.10.10.25
Total Common Equity
-132.14-113.34-77.93
Shareholders' Equity
144.9289124.41
Total Liabilities & Equity
156.7697.22150.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
3.162.754.77
Net Cash (Debt)
144.9388.44136.25
Net Cash Growth
--35.09%-
Net Cash Per Share
10.096.2710.17
Filing Date Shares Outstanding
14.6514.3413.4
Total Common Shares Outstanding
14.6514.3413.4
Working Capital
117.5874.15116.5
Book Value Per Share
-9.02-7.90-5.82
Tangible Book Value
-132.14-113.34-77.93
Tangible Book Value Per Share
-9.02-7.90-5.82
Machinery
5.185.336.45
SEC Filings: 10-K · 10-Q